Frequently Asked Questions
The Europe pharmaceutical excipients market size will be worth USD 4,586.83 million by 2030.
The growth rate of the Europe pharmaceutical excipients market is 6.3% in the forecast by 2030.
Functionality, dosage forms, route of administration, end user, and distribution channel are the factors on which the Europe pharmaceutical excipients market research is based.
Growing pharmaceutical industry, advancements in drug formulation & advancements in biopharmaceuticals and biosimilars are the growth drivers of the Europe pharmaceutical excipients market.
Major companies in the Europe pharmaceutical excipients market are Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany), Omya AG (Switzerland), Peter Greven GmbH & Co. KG (Germany), Ashland (U.S.), Evonik (Germany), Dow (U.S.), Croda International Plc (United Kingdom), Roquette Frères (France), The Lubrizol Corporation (U.S.), BASF SE (Germany), Avantor, Inc. (U.S.), BENEO (Germany), Chemie Trade (U.S.)
